Shuliang Guo

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +11

Endobronchial ultrasound and bronchial artery embolization for Dieulafoy's disease of the bronchus in a teenager: A case report

Oormila Ganganah, Shuliang Guo, Manu Chiniah et al. · Respiratory Medicine Case Reports · 2015 · 30 citations · Full text

Medicine, Pediatrics, Radiology +12

The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study

Wanli Kang, Jian Du, Song‐I Yang et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2020 · 27 citations

Medicine, Geriatric Medicine, Population Health +10

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal for ImmunoTherapy of Cancer · 2024 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

Relationship between serum iron and blood eosinophil counts in asthmatic adults: data from NHANES 2011-2018

Jun Wen, Changfen Wang, Jing Xia et al. · Frontiers in Immunology · 2023 · 23 citations · Full text

Public Health, Immunology, Internal Medicine +14